StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
632
This month
9
This week
4
This year
56
Today
1
Yesterday
1
Publishing Date
2024 - 03 - 25
3
2024 - 02 - 06
3
2024 - 01 - 08
3
2023 - 11 - 06
3
2023 - 10 - 16
3
2023 - 05 - 09
4
2023 - 03 - 13
3
2023 - 03 - 02
3
2023 - 02 - 07
3
2022 - 11 - 04
4
2022 - 11 - 02
3
2022 - 09 - 05
3
2022 - 06 - 20
3
2022 - 05 - 11
4
2022 - 05 - 03
6
2022 - 05 - 02
3
2022 - 04 - 05
3
2022 - 03 - 28
4
2022 - 03 - 24
4
2022 - 02 - 21
3
2022 - 01 - 04
3
2021 - 11 - 12
3
2021 - 11 - 09
4
2021 - 11 - 05
3
2021 - 09 - 15
2
2021 - 08 - 31
2
2021 - 08 - 30
3
2021 - 08 - 25
2
2021 - 08 - 16
2
2021 - 08 - 11
2
2021 - 08 - 09
2
2021 - 08 - 06
3
2021 - 08 - 04
2
2021 - 07 - 29
3
2021 - 07 - 22
2
2021 - 07 - 12
3
2021 - 07 - 09
2
2021 - 06 - 26
2
2021 - 06 - 22
2
2021 - 06 - 21
2
2021 - 06 - 16
3
2021 - 06 - 14
2
2021 - 06 - 09
2
2021 - 06 - 07
2
2021 - 05 - 28
3
2021 - 05 - 27
3
2021 - 05 - 25
3
2021 - 05 - 11
3
2021 - 05 - 07
3
2021 - 05 - 04
2
2021 - 04 - 21
2
2021 - 04 - 19
2
2021 - 04 - 13
2
2021 - 04 - 08
2
2021 - 03 - 29
2
2021 - 03 - 25
3
2021 - 03 - 18
4
2021 - 03 - 16
2
2021 - 03 - 15
2
2020 - 12 - 07
2
Sector
Commercial services
5
Communications
2
Consumer durables
2
Consumer non-durables
3
Consumer services
1
Distribution services
1
Electronic technology
5
Energy minerals
1
Finance
14
Finance and insurance
3
Health care and social assistance
1
Health services
4
Health technology
632
Manufacturing
17
N/a
7
Process industries
1
Producer manufacturing
1
Professional, scientific, and technical services
4
Retail trade
2
Technology services
4
Tags
Acquire
7
Agreement
5
Application
6
Approval
7
Biotech
7
Biotechnology
5
Bleeding
7
Blood
5
Cancer
5
Cardiovascular
5
Collaboration
8
Companies
6
Conference
20
Device
5
Diabetes
34
Disease
18
Drug
18
Earnings
8
Europe
10
Events
22
Expansion
7
Expected
10
Fda
11
Financial
7
Financial results
7
Genetown
7
Global
45
Growing
5
Growth
33
Hormone
7
Insulin
32
Iot
6
Kidney
5
Liver
11
Market
79
Money
7
N/a
517
Obesity
16
People
11
Pharma
81
Pharmaceutical
12
Phase 2
7
Phase 3
6
Program
10
Reach
10
Report
39
Repurchase
96
Research
34
Results
20
S
42
Sales
13
Sanofi
7
Study
6
Technology
10
Therapeutics
27
Therapy
11
Treatment
34
Trial
32
Trials
8
Update
12
Entities
89bio, inc.
2
Abbott laboratories
20
Abbvie inc.
14
Alnylam pharmaceuticals, inc.
25
Altimmune, inc.
2
Amazon.com, inc.
2
Amgen inc.
17
Astellas pharma inc
3
Astrazeneca plc
30
Bausch health companies inc.
2
Baxter international inc.
8
Becton, dickinson and company
12
Biogen inc.
7
Blackrock, inc.
5
Bnp paribas
3
Boston scientific corporation
3
Bristol-myers squibb company
7
Catalent, inc.
2
Charles river laboratories international, inc.
2
Csl ltd
3
Denali therapeutics inc.
2
Dexcom, inc.
3
Eiger biopharmaceuticals, inc.
2
Eli lilly and company
83
Endo international plc
5
Entera bio ltd.
2
Forma therapeutics holdings, inc.
2
Galectin therapeutics inc.
3
Genmab a/s
4
Gilead sciences, inc.
10
Glaukos corporation
2
Glaxosmithkline plc
27
Global blood therapeutics, inc.
2
Icon plc
5
Incannex healthcare ltd
2
Innate pharma s.a.
71
Innate pharma sa
44
Insulet corporation
11
Ionis pharmaceuticals, inc.
3
Iqvia holdings, inc.
2
Johnson & johnson
44
Kamada ltd.
2
Karyopharm therapeutics inc.
2
Lipocine inc.
3
Madrigal pharmaceuticals, inc.
3
Mallinckrodt plc
2
Medtronic plc
14
Novartis ag
28
Novo nordisk a/s
632
Pfizer, inc.
11
Regeneron pharmaceuticals, inc.
4
Retractable technologies, inc.
4
Sanofi
139
Takeda pharmaceutical company limited
15
Terumo corp
9
Teva pharmaceutical industries ltd
15
Thermo fisher scientific inc
4
Vertex pharmaceuticals incorporated
3
Viatris inc.
7
Zealand pharma a/s
9
Symbols
AAPL
1198
ABB
1427
ABBV
1024
ABLZF
1166
ABT
1787
ACN
600
AMGN
742
ARVL
4294
AVGO
593
AZN
665
BDX
796
BMY
662
BNPQF
1764
BNPQY
1764
CSCO
897
DHR
785
ERIC
1612
F
641
FNCTF
7191
FRBA
598
GE
917
GLAXF
658
GOOG
1281
GOOGL
1280
GSK
884
HON
1787
HUBS
1400
IBM
655
INTC
955
IT
594
JNJ
4583
LLY
1709
LTUM
971
LYV
717
MDT
1285
MMM
938
MS
4286
MSFT
1201
MT
589
NOK
901
NOKBF
975
NVO
632
NVS
1241
NVSEF
1031
ORCL
1158
PCRFF
650
PCRFY
650
PFE
692
PHG
962
PPRUF
1128
PPRUY
1129
SAP
1477
SAPGF
1231
SNOW
796
SNY
4539
SNYNF
3597
TEVJF
631
TMO
1622
VZ
1213
XYF
676
Exchanges
Amex
5
Nasdaq
251
Nyse
632
Crawled Date
2024 - 03 - 25
3
2024 - 02 - 06
3
2024 - 01 - 08
3
2023 - 11 - 06
3
2023 - 10 - 16
3
2023 - 09 - 13
3
2023 - 05 - 09
4
2023 - 03 - 13
3
2023 - 03 - 02
3
2023 - 02 - 23
3
2023 - 02 - 07
3
2022 - 11 - 04
4
2022 - 11 - 02
3
2022 - 09 - 05
3
2022 - 06 - 20
3
2022 - 05 - 11
4
2022 - 05 - 03
6
2022 - 05 - 02
3
2022 - 04 - 05
3
2022 - 03 - 28
4
2022 - 03 - 24
4
2022 - 02 - 21
3
2022 - 01 - 04
3
2021 - 11 - 12
3
2021 - 11 - 09
4
2021 - 11 - 05
3
2021 - 08 - 30
3
2021 - 08 - 25
2
2021 - 08 - 16
2
2021 - 08 - 11
2
2021 - 08 - 09
2
2021 - 08 - 06
3
2021 - 08 - 04
2
2021 - 07 - 29
3
2021 - 07 - 22
2
2021 - 07 - 12
3
2021 - 07 - 09
2
2021 - 06 - 27
2
2021 - 06 - 22
2
2021 - 06 - 21
2
2021 - 06 - 16
3
2021 - 06 - 14
2
2021 - 06 - 09
2
2021 - 06 - 07
2
2021 - 05 - 28
3
2021 - 05 - 27
3
2021 - 05 - 25
3
2021 - 05 - 11
3
2021 - 05 - 07
3
2021 - 05 - 04
2
2021 - 04 - 21
2
2021 - 04 - 19
2
2021 - 04 - 13
2
2021 - 04 - 08
2
2021 - 03 - 29
2
2021 - 03 - 25
3
2021 - 03 - 18
4
2021 - 03 - 16
2
2021 - 03 - 15
2
2020 - 12 - 07
2
Crawled Time
00:00
4
00:20
3
01:00
7
02:00
6
03:00
1
04:00
3
04:20
5
05:00
5
06:00
33
07:00
36
07:04
1
08:00
31
09:00
15
10:00
29
11:00
35
11:33
1
12:00
65
12:15
9
12:20
16
12:30
10
13:00
37
13:15
7
13:20
9
13:30
9
14:00
38
14:05
1
14:15
3
14:20
6
14:30
5
15:00
39
15:01
1
15:15
2
15:20
8
15:30
8
16:00
24
16:20
2
17:00
23
17:01
1
18:00
19
19:00
14
20:00
16
20:20
1
21:00
19
21:06
1
22:00
16
23:00
8
Source
www.aspenpharma.com
1
www.biospace.com
112
www.globenewswire.com
342
www.prnewswire.com
177
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
NVO
save search
Peptide Therapeutics Market Projected to Reach $57.97 billion by 2030 - Exclusive Report by 360iResearch
Published:
2024-04-19
(Crawled : 15:00)
- prnewswire.com
NVO
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
0.0%
|
O:
-0.75%
H:
0.0%
C:
0.0%
GSK
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
0.0%
|
O:
-0.56%
H:
0.0%
C:
0.0%
LLY
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
0.0%
|
O:
-0.21%
H:
0.0%
C:
0.0%
AZN
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
0.0%
|
O:
-0.15%
H:
0.0%
C:
0.0%
report
reach
therapeutics
market
Ventus Therapeutics Announces Results from Phase 1 Clinical Trial of VENT-02, a Novel, Orally Administered, Brain-Penetrant NLRP3 Inhibitor
Published:
2024-04-17
(Crawled : 14:00)
- biospace.com/
NVO
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
0.87%
|
O:
1.22%
H:
0.21%
C:
-0.34%
vent-02
trial
therapeutics
results
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published:
2024-04-15
(Crawled : 18:00)
- globenewswire.com
NVO
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
0.02%
|
O:
1.04%
H:
0.19%
C:
-1.52%
Novo Nordisk A/S - share repurchase programme
Published:
2024-04-15
(Crawled : 13:00)
- globenewswire.com
NVO
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
0.02%
|
O:
1.04%
H:
0.19%
C:
-1.52%
repurchase
Ventus Therapeutics to Present at 2024 Bloom Burton & Co. Healthcare Investor Conference
Published:
2024-04-08
(Crawled : 12:30)
- biospace.com/
NVO
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-0.35%
|
O:
1.62%
H:
0.5%
C:
0.36%
conference
therapeutics
Novo Nordisk A/S - share repurchase programme
Published:
2024-04-08
(Crawled : 13:30)
- globenewswire.com
NVO
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-0.35%
|
O:
1.62%
H:
0.5%
C:
0.36%
repurchase
REDUCED secures EUR 6 million financing led by Novo Holdings to scale its natural food ingredients business
Published:
2024-04-04
(Crawled : 06:00)
- prnewswire.com
NVO
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-0.78%
|
O:
1.1%
H:
0.46%
C:
-2.32%
business
natural
million
food
2023 Novo Holdings Asia Investments Annual Review/Business Update
Published:
2024-04-03
(Crawled : 07:00)
- prnewswire.com
NVO
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-1.53%
|
O:
-0.75%
H:
0.0%
C:
0.0%
investments
update
asia
Novo Nordisk A/S - share repurchase programme
Published:
2024-04-02
(Crawled : 11:00)
- globenewswire.com
NVO
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-2.37%
|
O:
-1.96%
H:
1.3%
C:
1.13%
repurchase
Novo Nordisk A/S - Articles of Association 2024
Published:
2024-03-25
(Crawled : 08:00)
- globenewswire.com
NVO
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-3.29%
|
O:
0.19%
H:
0.97%
C:
0.04%
association
Novo Nordisk to acquire Cardior Pharmaceuticals and strengthen pipeline in cardiovascular disease
Published:
2024-03-25
(Crawled : 10:00)
- globenewswire.com
NVO
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-3.29%
|
O:
0.19%
H:
0.97%
C:
0.04%
disease
pipeline
pharmaceuticals
acquire
cardiovascular
Novo Nordisk A/S - share repurchase programme
Published:
2024-03-25
(Crawled : 12:00)
- globenewswire.com
NVO
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-3.29%
|
O:
0.19%
H:
0.97%
C:
0.04%
repurchase
Resolutions from the Annual General Meeting of Novo Nordisk A/S
Published:
2024-03-21
(Crawled : 15:00)
- globenewswire.com
NVO
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-4.47%
|
O:
-1.04%
H:
1.6%
C:
0.64%
meeting
Awiqli® (once-weekly basal insulin icodec) recommended for approval for the treatment of diabetes by the European regulatory authorities
Published:
2024-03-21
(Crawled : 16:00)
- globenewswire.com
NVO
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-4.47%
|
O:
-1.04%
H:
1.6%
C:
0.64%
awiqli
approval
treatment
diabetes
insulin
Novo Nordisk A/S - share repurchase programme
Published:
2024-03-18
(Crawled : 14:00)
- globenewswire.com
NVO
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-5.92%
|
O:
-0.6%
H:
1.66%
C:
1.0%
repurchase
2023 Novo Holdings Bioindustrial Investments Team Annual Review/Business Update
Published:
2024-03-15
(Crawled : 09:00)
- prnewswire.com
NVO
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-7.47%
|
O:
-0.52%
H:
0.09%
C:
-1.13%
investments
update
Novo Holdings Portfolio Company Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca
Published:
2024-03-14
(Crawled : 08:00)
- prnewswire.com
NVO
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-6.71%
|
O:
1.77%
H:
0.05%
C:
-0.93%
pharma
company
astrazeneca
acquired
agreement
Global Antidiabetics Market 10 Year Forecast Report 2024-2034, by Product Type, by Application, by Distribution Channel and Region
Published:
2024-03-13
(Crawled : 18:00)
- prnewswire.com
NVO
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-7.83%
|
O:
-0.64%
H:
0.94%
C:
-0.56%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-10.2%
|
O:
0.66%
H:
0.0%
C:
0.0%
LLY
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-0.55%
|
O:
0.27%
H:
0.5%
C:
0.11%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-11.47%
|
O:
0.41%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-5.85%
|
O:
-0.04%
H:
0.0%
C:
0.0%
report
distribution
year
global
market
Novo Holdings reports Total Income and Investment Returns of DKK 31 billion (€4.2 billion) for 2023. Total Assets grow by 38% to DKK 1,114 billion (€149 billion)
Published:
2024-03-12
(Crawled : 07:00)
- prnewswire.com
NVO
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-5.11%
|
O:
0.27%
H:
2.67%
C:
2.67%
total
Novo Nordisk A/S - share repurchase programme
Published:
2024-03-11
(Crawled : 13:00)
- globenewswire.com
NVO
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-6.42%
|
O:
0.23%
H:
0.11%
C:
-1.6%
repurchase
← Previous
1
2
3
4
5
6
7
8
9
…
31
32
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
News
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.